Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical […]
HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical […]
ASC 606 Second Quarter Results Revenues of $590.4 million GAAP net earnings attributable to CDK of $89.0 million and adjusted […]
GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical […]
VANCOUVER, British Columbia, Feb. 05, 2019 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the “Company”, […]
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) — Datametrex AI Limited (TSXV:DM) (the “Company” or “Datametrex”) is pleased to announce its […]
ATCHISON, Kan., Feb. 05, 2019 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and […]
~Pharmacokinetic data from patients treated in the study show that infusion of pegunigalsidase alfa every 4 weeks results in the presence […]
REHOVOT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today […]
BERKELEY HEIGHTS, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]
BALA CYNWYD, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) […]